Data for end-stage kidney disease in the United States available online

NewsGuard 100/100 Score

Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.

"These tables provide preliminary estimates, which may change minimally as additional updates become available," said Paul W. Eggers, Ph.D., who directs the NIDDK's kidney and urology epidemiology programs. "However, these frequent updates will allow researchers to see and investigate trends sooner than previously possible."

The first of the new tables shows incidence and prevalence counts through December 2008. As the tables are updated quarterly, an additional three months of counts will be added. The next update in December 2009 will include patient counts through March 2009.

Previously, incidence and prevalence data had been made available only through yearly updates of the USRDS Annual Data Report (www.usrds.org/adr.htm). Because the report includes detailed data from multiple sources, reporting lagged by about 18 months while data were merged and verified. For example, the 2009 report, which became available this month, has complete data only through 2007.

Data from the USRDS is used by researchers, government officials, health program planners, and others to develop research goals, assess public health needs, set program priorities, and inform policymakers and the public.

More than half a million people in the United States have end-stage kidney disease, requiring frequent dialysis treatments or a kidney transplant. People with the disease account for just 1.2 percent of the Medicare population, but accounted for 7.3 percent of Medicare costs in 2007. The total cost for the disease was $35.32 billion, including coverage by Medicare and other payers, such as employer group health plans.

The USRDS, funded by the NIDDK, collaborates with the Centers for Medicare and Medicaid Services, ESRD Networks and the United Network for Organ Sharing in sharing datasets and improving the accuracy of information.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combining blood pressure drug with dietary-resistant starch may help stave off diabetic kidney disease